{"nct_id":"NCT06280391","title":"A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2024-02-20","start_date_type":"ACTUAL","primary_completion_date":"2026-03-24","primary_completion_date_type":"ESTIMATED","completion_date":"2026-08-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["SNY"]}